nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—Prednisone—ankylosing spondylitis	0.174	0.346	CbGbCtD
Nilutamide—CYP2C8—Dexamethasone—ankylosing spondylitis	0.129	0.258	CbGbCtD
Nilutamide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.108	0.216	CbGbCtD
Nilutamide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0901	0.18	CbGbCtD
Nilutamide—Interstitial pneumonia—Methotrexate—ankylosing spondylitis	0.00813	0.0163	CcSEcCtD
Nilutamide—Cough increased—Triamcinolone—ankylosing spondylitis	0.0065	0.013	CcSEcCtD
Nilutamide—Cataract—Triamcinolone—ankylosing spondylitis	0.00625	0.0125	CcSEcCtD
Nilutamide—Cataract—Dexamethasone—ankylosing spondylitis	0.00567	0.0114	CcSEcCtD
Nilutamide—Cataract—Betamethasone—ankylosing spondylitis	0.00567	0.0114	CcSEcCtD
Nilutamide—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.00555	0.0111	CcSEcCtD
Nilutamide—Lung disorder—Methotrexate—ankylosing spondylitis	0.00555	0.0111	CcSEcCtD
Nilutamide—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00496	0.00993	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00495	0.00993	CcSEcCtD
Nilutamide—Cataract—Prednisone—ankylosing spondylitis	0.00494	0.0099	CcSEcCtD
Nilutamide—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00441	0.00885	CcSEcCtD
Nilutamide—Dry skin—Prednisolone—ankylosing spondylitis	0.0043	0.00863	CcSEcCtD
Nilutamide—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00413	0.00829	CcSEcCtD
Nilutamide—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00413	0.00829	CcSEcCtD
Nilutamide—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00401	0.00805	CcSEcCtD
Nilutamide—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00401	0.00805	CcSEcCtD
Nilutamide—Melaena—Methotrexate—ankylosing spondylitis	0.00384	0.00769	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.0038	0.00762	CcSEcCtD
Nilutamide—Influenza—Triamcinolone—ankylosing spondylitis	0.00373	0.00748	CcSEcCtD
Nilutamide—Dry skin—Dexamethasone—ankylosing spondylitis	0.00359	0.0072	CcSEcCtD
Nilutamide—Dry skin—Betamethasone—ankylosing spondylitis	0.00359	0.0072	CcSEcCtD
Nilutamide—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00351	0.00705	CcSEcCtD
Nilutamide—Cardiac failure—Prednisone—ankylosing spondylitis	0.0035	0.00701	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00347	0.00695	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00341	0.00684	CcSEcCtD
Nilutamide—Sweating—Methylprednisolone—ankylosing spondylitis	0.00318	0.00638	CcSEcCtD
Nilutamide—Visual impairment—Prednisolone—ankylosing spondylitis	0.00313	0.00628	CcSEcCtD
Nilutamide—Dry skin—Prednisone—ankylosing spondylitis	0.00313	0.00627	CcSEcCtD
Nilutamide—Weight decreased—Betamethasone—ankylosing spondylitis	0.00306	0.00614	CcSEcCtD
Nilutamide—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00306	0.00614	CcSEcCtD
Nilutamide—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00305	0.00612	CcSEcCtD
Nilutamide—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00305	0.00612	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00301	0.00603	CcSEcCtD
Nilutamide—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00301	0.00603	CcSEcCtD
Nilutamide—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00299	0.006	CcSEcCtD
Nilutamide—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00299	0.00599	CcSEcCtD
Nilutamide—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00287	0.00576	CcSEcCtD
Nilutamide—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00272	0.00545	CcSEcCtD
Nilutamide—Weight decreased—Prednisone—ankylosing spondylitis	0.00267	0.00535	CcSEcCtD
Nilutamide—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00266	0.00533	CcSEcCtD
Nilutamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00262	0.00526	CcSEcCtD
Nilutamide—Depression—Prednisone—ankylosing spondylitis	0.00262	0.00526	CcSEcCtD
Nilutamide—Visual impairment—Betamethasone—ankylosing spondylitis	0.00261	0.00524	CcSEcCtD
Nilutamide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00261	0.00524	CcSEcCtD
Nilutamide—Malaise—Prednisolone—ankylosing spondylitis	0.00255	0.00511	CcSEcCtD
Nilutamide—Syncope—Prednisolone—ankylosing spondylitis	0.00254	0.00508	CcSEcCtD
Nilutamide—Back pain—Triamcinolone—ankylosing spondylitis	0.00252	0.00504	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00249	0.00498	CcSEcCtD
Nilutamide—Hypertension—Prednisolone—ankylosing spondylitis	0.00244	0.0049	CcSEcCtD
Nilutamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00241	0.00484	CcSEcCtD
Nilutamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00241	0.00483	CcSEcCtD
Nilutamide—Alopecia—Dexamethasone—ankylosing spondylitis	0.0024	0.0048	CcSEcCtD
Nilutamide—Alopecia—Betamethasone—ankylosing spondylitis	0.0024	0.0048	CcSEcCtD
Nilutamide—Discomfort—Prednisolone—ankylosing spondylitis	0.00238	0.00477	CcSEcCtD
Nilutamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00235	0.0047	CcSEcCtD
Nilutamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00234	0.00469	CcSEcCtD
Nilutamide—Syncope—Triamcinolone—ankylosing spondylitis	0.00233	0.00468	CcSEcCtD
Nilutamide—Syncope—Methylprednisolone—ankylosing spondylitis	0.00233	0.00467	CcSEcCtD
Nilutamide—Oedema—Prednisolone—ankylosing spondylitis	0.00231	0.00463	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00229	0.00459	CcSEcCtD
Nilutamide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00229	0.00458	CcSEcCtD
Nilutamide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00228	0.00457	CcSEcCtD
Nilutamide—Shock—Prednisolone—ankylosing spondylitis	0.00227	0.00455	CcSEcCtD
Nilutamide—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00227	0.00455	CcSEcCtD
Nilutamide—Cough—Triamcinolone—ankylosing spondylitis	0.00227	0.00455	CcSEcCtD
Nilutamide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00225	0.0045	CcSEcCtD
Nilutamide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00224	0.00449	CcSEcCtD
Nilutamide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00223	0.00447	CcSEcCtD
Nilutamide—Pneumonia—Methotrexate—ankylosing spondylitis	0.00221	0.00443	CcSEcCtD
Nilutamide—Depression—Methotrexate—ankylosing spondylitis	0.00219	0.00439	CcSEcCtD
Nilutamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00219	0.00439	CcSEcCtD
Nilutamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00219	0.00439	CcSEcCtD
Nilutamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00219	0.00439	CcSEcCtD
Nilutamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00218	0.00438	CcSEcCtD
Nilutamide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00217	0.00434	CcSEcCtD
Nilutamide—Malaise—Betamethasone—ankylosing spondylitis	0.00213	0.00427	CcSEcCtD
Nilutamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00213	0.00427	CcSEcCtD
Nilutamide—Oedema—Triamcinolone—ankylosing spondylitis	0.00212	0.00426	CcSEcCtD
Nilutamide—Syncope—Dexamethasone—ankylosing spondylitis	0.00212	0.00424	CcSEcCtD
Nilutamide—Syncope—Betamethasone—ankylosing spondylitis	0.00212	0.00424	CcSEcCtD
Nilutamide—Sweating—Methotrexate—ankylosing spondylitis	0.00211	0.00422	CcSEcCtD
Nilutamide—Haematuria—Methotrexate—ankylosing spondylitis	0.0021	0.0042	CcSEcCtD
Nilutamide—Shock—Triamcinolone—ankylosing spondylitis	0.00209	0.00419	CcSEcCtD
Nilutamide—Insomnia—Prednisolone—ankylosing spondylitis	0.00209	0.00419	CcSEcCtD
Nilutamide—Alopecia—Prednisone—ankylosing spondylitis	0.00209	0.00418	CcSEcCtD
Nilutamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00208	0.00418	CcSEcCtD
Nilutamide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00207	0.00416	CcSEcCtD
Nilutamide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00207	0.00416	CcSEcCtD
Nilutamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00207	0.00416	CcSEcCtD
Nilutamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00205	0.00411	CcSEcCtD
Nilutamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00205	0.0041	CcSEcCtD
Nilutamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00204	0.00408	CcSEcCtD
Nilutamide—Hypertension—Betamethasone—ankylosing spondylitis	0.00204	0.00408	CcSEcCtD
Nilutamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00198	0.00398	CcSEcCtD
Nilutamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00198	0.00398	CcSEcCtD
Nilutamide—Pain—Prednisolone—ankylosing spondylitis	0.00197	0.00396	CcSEcCtD
Nilutamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00195	0.00391	CcSEcCtD
Nilutamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00193	0.00388	CcSEcCtD
Nilutamide—Oedema—Betamethasone—ankylosing spondylitis	0.00193	0.00386	CcSEcCtD
Nilutamide—Oedema—Dexamethasone—ankylosing spondylitis	0.00193	0.00386	CcSEcCtD
Nilutamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00192	0.00385	CcSEcCtD
Nilutamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00192	0.00384	CcSEcCtD
Nilutamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00191	0.00382	CcSEcCtD
Nilutamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00191	0.00382	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0019	0.00381	CcSEcCtD
Nilutamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.0019	0.00381	CcSEcCtD
Nilutamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.0019	0.00381	CcSEcCtD
Nilutamide—Anaemia—Prednisone—ankylosing spondylitis	0.0019	0.00381	CcSEcCtD
Nilutamide—Shock—Betamethasone—ankylosing spondylitis	0.00189	0.0038	CcSEcCtD
Nilutamide—Shock—Dexamethasone—ankylosing spondylitis	0.00189	0.0038	CcSEcCtD
Nilutamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00189	0.00379	CcSEcCtD
Nilutamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00187	0.00375	CcSEcCtD
Nilutamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00186	0.00374	CcSEcCtD
Nilutamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00186	0.00373	CcSEcCtD
Nilutamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00186	0.00373	CcSEcCtD
Nilutamide—Malaise—Prednisone—ankylosing spondylitis	0.00185	0.00372	CcSEcCtD
Nilutamide—Syncope—Prednisone—ankylosing spondylitis	0.00184	0.00369	CcSEcCtD
Nilutamide—Anorexia—Betamethasone—ankylosing spondylitis	0.00184	0.00368	CcSEcCtD
Nilutamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00184	0.00368	CcSEcCtD
Nilutamide—Pain—Triamcinolone—ankylosing spondylitis	0.00181	0.00364	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00181	0.00362	CcSEcCtD
Nilutamide—Hypertension—Prednisone—ankylosing spondylitis	0.00177	0.00356	CcSEcCtD
Nilutamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00175	0.00351	CcSEcCtD
Nilutamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00175	0.0035	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—ankylosing spondylitis	0.00174	0.0035	CcSEcCtD
Nilutamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00174	0.00349	CcSEcCtD
Nilutamide—Insomnia—Betamethasone—ankylosing spondylitis	0.00174	0.00349	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00173	0.00347	CcSEcCtD
Nilutamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00173	0.00347	CcSEcCtD
Nilutamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00173	0.00347	CcSEcCtD
Nilutamide—Discomfort—Prednisone—ankylosing spondylitis	0.00173	0.00347	CcSEcCtD
Nilutamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.0017	0.0034	CcSEcCtD
Nilutamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.0017	0.0034	CcSEcCtD
Nilutamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00168	0.00336	CcSEcCtD
Nilutamide—Oedema—Prednisone—ankylosing spondylitis	0.00168	0.00336	CcSEcCtD
Nilutamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00167	0.00336	CcSEcCtD
Nilutamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00167	0.00336	CcSEcCtD
Nilutamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00167	0.00336	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00166	0.00333	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00166	0.00333	CcSEcCtD
Nilutamide—Back pain—Methotrexate—ankylosing spondylitis	0.00166	0.00333	CcSEcCtD
Nilutamide—Shock—Prednisone—ankylosing spondylitis	0.00165	0.00331	CcSEcCtD
Nilutamide—Pain—Dexamethasone—ankylosing spondylitis	0.00165	0.0033	CcSEcCtD
Nilutamide—Pain—Betamethasone—ankylosing spondylitis	0.00165	0.0033	CcSEcCtD
Nilutamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00162	0.00325	CcSEcCtD
Nilutamide—Anorexia—Prednisone—ankylosing spondylitis	0.0016	0.00321	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00319	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—ankylosing spondylitis	0.00159	0.00318	CcSEcCtD
Nilutamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00159	0.00318	CcSEcCtD
Nilutamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00159	0.00318	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Nilutamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Nilutamide—Malaise—Methotrexate—ankylosing spondylitis	0.00155	0.00311	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00154	0.00308	CcSEcCtD
Nilutamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00153	0.00306	CcSEcCtD
Nilutamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00152	0.00305	CcSEcCtD
Nilutamide—Insomnia—Prednisone—ankylosing spondylitis	0.00152	0.00304	CcSEcCtD
Nilutamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00151	0.00302	CcSEcCtD
Nilutamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.0015	0.00301	CcSEcCtD
Nilutamide—Cough—Methotrexate—ankylosing spondylitis	0.0015	0.003	CcSEcCtD
Nilutamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0015	0.003	CcSEcCtD
Nilutamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00148	0.00296	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—ankylosing spondylitis	0.00146	0.00293	CcSEcCtD
Nilutamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00146	0.00292	CcSEcCtD
Nilutamide—Rash—Prednisolone—ankylosing spondylitis	0.00146	0.00292	CcSEcCtD
Nilutamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00145	0.00291	CcSEcCtD
Nilutamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00145	0.00291	CcSEcCtD
Nilutamide—Headache—Prednisolone—ankylosing spondylitis	0.00145	0.0029	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00144	0.0029	CcSEcCtD
Nilutamide—Constipation—Prednisone—ankylosing spondylitis	0.00143	0.00288	CcSEcCtD
Nilutamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.0014	0.00281	CcSEcCtD
Nilutamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0014	0.00281	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00138	0.00277	CcSEcCtD
Nilutamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00138	0.00277	CcSEcCtD
Nilutamide—Asthenia—Betamethasone—ankylosing spondylitis	0.00138	0.00277	CcSEcCtD
Nilutamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00137	0.00275	CcSEcCtD
Nilutamide—Nausea—Prednisolone—ankylosing spondylitis	0.00137	0.00275	CcSEcCtD
Nilutamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00136	0.00273	CcSEcCtD
Nilutamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00136	0.00273	CcSEcCtD
Nilutamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00135	0.00272	CcSEcCtD
Nilutamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00135	0.00271	CcSEcCtD
Nilutamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00135	0.0027	CcSEcCtD
Nilutamide—Rash—Triamcinolone—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Nilutamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Nilutamide—Rash—Methylprednisolone—ankylosing spondylitis	0.00134	0.00268	CcSEcCtD
Nilutamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00133	0.00267	CcSEcCtD
Nilutamide—Headache—Triamcinolone—ankylosing spondylitis	0.00133	0.00267	CcSEcCtD
Nilutamide—Headache—Methylprednisolone—ankylosing spondylitis	0.00133	0.00266	CcSEcCtD
Nilutamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00133	0.00266	CcSEcCtD
Nilutamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00133	0.00266	CcSEcCtD
Nilutamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00132	0.00264	CcSEcCtD
Nilutamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00132	0.00264	CcSEcCtD
Nilutamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00127	0.00255	CcSEcCtD
Nilutamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00127	0.00255	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—ankylosing spondylitis	0.00127	0.00254	CcSEcCtD
Nilutamide—Nausea—Triamcinolone—ankylosing spondylitis	0.00126	0.00253	CcSEcCtD
Nilutamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00126	0.00252	CcSEcCtD
Nilutamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00126	0.00252	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00125	0.00251	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00123	0.00247	CcSEcCtD
Nilutamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00122	0.00245	CcSEcCtD
Nilutamide—Vomiting—Betamethasone—ankylosing spondylitis	0.00122	0.00245	CcSEcCtD
Nilutamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00122	0.00244	CcSEcCtD
Nilutamide—Rash—Betamethasone—ankylosing spondylitis	0.00121	0.00243	CcSEcCtD
Nilutamide—Rash—Dexamethasone—ankylosing spondylitis	0.00121	0.00243	CcSEcCtD
Nilutamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00121	0.00243	CcSEcCtD
Nilutamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00121	0.00243	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00243	CcSEcCtD
Nilutamide—Headache—Betamethasone—ankylosing spondylitis	0.00121	0.00242	CcSEcCtD
Nilutamide—Headache—Dexamethasone—ankylosing spondylitis	0.00121	0.00242	CcSEcCtD
Nilutamide—Asthenia—Prednisone—ankylosing spondylitis	0.0012	0.00241	CcSEcCtD
Nilutamide—Pain—Methotrexate—ankylosing spondylitis	0.0012	0.0024	CcSEcCtD
Nilutamide—Pruritus—Prednisone—ankylosing spondylitis	0.00119	0.00238	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00115	0.00232	CcSEcCtD
Nilutamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00115	0.0023	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00115	0.0023	CcSEcCtD
Nilutamide—Nausea—Dexamethasone—ankylosing spondylitis	0.00114	0.00229	CcSEcCtD
Nilutamide—Nausea—Betamethasone—ankylosing spondylitis	0.00114	0.00229	CcSEcCtD
Nilutamide—Dizziness—Prednisone—ankylosing spondylitis	0.00111	0.00222	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00111	0.00222	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00111	0.00222	CcSEcCtD
Nilutamide—Vomiting—Prednisone—ankylosing spondylitis	0.00107	0.00214	CcSEcCtD
Nilutamide—Rash—Prednisone—ankylosing spondylitis	0.00106	0.00212	CcSEcCtD
Nilutamide—Dermatitis—Prednisone—ankylosing spondylitis	0.00106	0.00212	CcSEcCtD
Nilutamide—Headache—Prednisone—ankylosing spondylitis	0.00105	0.00211	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—ankylosing spondylitis	0.00101	0.00202	CcSEcCtD
Nilutamide—Nausea—Prednisone—ankylosing spondylitis	0.000996	0.002	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000992	0.00199	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000959	0.00192	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000927	0.00186	CcSEcCtD
Nilutamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000891	0.00179	CcSEcCtD
Nilutamide—Rash—Methotrexate—ankylosing spondylitis	0.000884	0.00177	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000883	0.00177	CcSEcCtD
Nilutamide—Headache—Methotrexate—ankylosing spondylitis	0.000878	0.00176	CcSEcCtD
Nilutamide—Nausea—Methotrexate—ankylosing spondylitis	0.000833	0.00167	CcSEcCtD
